Selected Grants
Implementation strategies to advance cardiovascular health in children with lupus
ResearchPrincipal Investigator · Awarded by Boston Children's Hospital · 2026 - 2032INNOVATE (Integrated National Network for Obstetric and Pediatric AdVAncement in Therapeutic Education)
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2026 - 2031Azathioprine Safety and Pharmacokinetics in Pregnant Women with Rheumatic Disease and their Infants
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2026 - 2031PTN 3.0 Task Order #2_ BPCA Pediatric Drug Development Clinical Trial Infrastructure
ResearchProject Leader · Awarded by National Institutes of Health · 2025 - 2030Pharmacokinetic Modeling to Optimize Dosing in Pediatric Rheumatic Diseases
ResearchPrincipal Investigator · Awarded by Thrasher Research Fund · 2025 - 2028Duke Summer Training in Academic Research - Advanced Methods Training (STAR - AMT)
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2026 - 2027Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2021 - 2027Improving Neonatal health Through Rapid malaria testing in Early Pregnancy with high-sensitivity Diagnostics (INTREPiD)
ResearchCo Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027Induced Suppression of Platelet Activity in Aneurysmal SAH Management-2 (iSPASM-2)
Clinical TrialInvestigator · Awarded by National Institutes of Health · 2025 - 2026PTN 2.0 TO #11: CUDDLE 2.0
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2026OxyContin Pediatric PMR Study
ResearchPrincipal Investigator · Awarded by Purdue Pharma · 2022 - 2026BPCA Data Closeout, Results Dissemination, And Stakeholder Engagement (Version 2.0)
ResearchPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2025Optimal Dosing for Biologic Agents in Obese Patients with Rheumatoid and Juvenile Arthritis
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2025PRECISE Study (Precision Biologics in Rheumatology)
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2021 - 2025Optimizing Hydroxychloroquine to Reduce Disease Activity in Pediatric Lupus
ResearchMentor · Awarded by Thrasher Research Fund · 2021 - 2023PTN 2.0 TO#4 BPCA Data Closeout and Dissemination - Option 4
ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2022 - 2023Global Pediatric Clinical Trials Network
ResearchCo Investigator · Awarded by Food and Drug Administration · 2017 - 2023PTN2- TO# BPCA Pharmacology Studies
ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2018 - 2023Vamorolone in Juvenile Autoimmune Myositis
Clinical TrialCo Investigator · Awarded by Cure JM Foundation · 2020 - 2022PTN 2.0- TO#4/Option 3 Data Closeout and Dissemination
ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2021 - 2022CARRA Registry Assistant Scientific Director
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2021 - 2022RTOP 18-0006 Option 1 / Protocol Implementation
Clinical TrialSite PI · Awarded by National Institute of Allergy and Infectious Diseases · 2019 - 2022RTOP 18-0006 Option 1 / Protocol Implementation
Clinical TrialMedical Monitor · Awarded by National Institute of Allergy and Infectious Diseases · 2019 - 2021HCQ Pharmacokinetics in Pediatric Lupus
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2019 - 2020PTN2- TO# Data Closeout and Dissemination
ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2018 - 2019ACR/Amgen Rheumatology Fellowship Training Award
FellowshipFellow · Awarded by Rheumatology Research Foundation · 2015 - 2016External Relationships
- Johnson and Johnson
- NIH
- ReveraGen
- Rutgers University
- The Childhood Arthritis and Rheumatology Research Alliance (CARRA)
- UCB Pharma
- US Food and Drug Administration
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.